(In Swedish)
Commenting CEO Transition, interview by Redeye
read more
News
News
IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics
IDL Biotech wants to focus on rapid diagnostic tests and automated assays of its tumor markers. By licensing the platform ELISA to Beckman Coulter, we can focus our resources on streamlining and developing the other platforms, said Gunnar Wahlberg, CEO of IDL...
IDL Biotech develops rapid test for breast cancer
In recent years IDL Biotech has been working on developing a rapid test to detect lung cancer, under the project name MonoTotal® Rapid. However, further development will instead focus on creating a rapid test for breast cancer. Read the article here (Swedish)
AroCell TK 210 ELISA can now be used on automated platforms
Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay. We have now validated AroCell TK 210 ELISA for use on an automation platform,...
Redeye interview with Michael Brobjer
A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020. See the interview on Redeye's website.
Business Development Manager Asia
IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF. Read the press release here
New research note on AroCells previous analysis from Redeye
Redeye has today released a new research note on the previous analysis of Arocell. The full report can be found on their website. Link to Redeye's new research note.
AroCell Strategy day 2020
Time: 10.00 - 12.00 CEST, June 15th 2020 On June 15, Arocell AB provides a live broadcast business update with subsequent question time led by Redeye’s analyst Oscar Bergman. CEO Michael Brobjer, together with parts of the management team, will among other things...
New article in DI
Link
AACR 2020: New data on AroCell TK 210 ELISA now online
Two abstracts accepted for the American Association of Cancer Research 2020 (AACR 2020) has now been published online. The first study entitled “Evaluation of TK1 protein changes using the AroCell TK 210 ELISA in an acute myeloid leukemia (AML) xenograft model during...
